Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure

Microbial Drug Resistance

Volumn 16, Issue 4, 2010, Pages 317-325

  Chia, Ju Hsin ^a,b   Su, Lin Hui ^a,b   Lee, Ming Hsun ^a   Kuo, An Jing ^a,b   Shih, Neng Yao ^c   Siu, Leung Kei ^b,c   Wu, Tsu Lan ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BACTERIAL PROTEIN; CARBAPENEM; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORINASE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; OMPK36 PROTEIN; TIGECYCLINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CLINICAL ARTICLE; FEMALE; HOSPITALIZATION; HUMAN; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; MALE; MEDICAL RECORD REVIEW; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; TAIWAN;

KLEBSIELLA PNEUMONIAE;

EID: 78649483901     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2009.0048     Document Type: Article

References (41)

1. Afzal-Shah, M., N. Woodford, and D.M. Livermore. 2001. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D b-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 45:583-588.
2. Bercault, N., and T. Boulain. 2001. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit. Care Med. 29:2303-2309.
3. Bradford, P.A., C. Urban, N. Mariano, S.J. Projan, J.J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC b-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569.
4. Brown, S.D., and M.M. Traczewski. 2007. Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control. J. Clin. Microbiol. 45:2173-2179.
5. Cao, V.T., G. Arlet, B.M. Ericsson, A. Tammelin, P. Courvalin, and T. Lambert. 2000. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J. Antimicrob. Chemother. 46:895-900.
6. Chia, J.H., C. Chu, L.H. Su, C.H. Chiu, A.J. Kuo, C.F. Sun, and T.L. Wu. 2005. Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M b-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan. J. Clin. Microbiol. 43:4486-4491.
7. Chia, J.H., L.K. Siu, L.H. Su, H.S. Lin, A.J. Kuo, M.H. Lee, and T.L. Wu. 2009. Emergence of carbapenem-resistant Escherichia coli in Taiwan: resistance due to combination of CMY-2 production and porin deficiency. J. Chemother. 21:621-626.
8. Chow, J.W., and D.M. Shlaes. 1991. Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes. J. Antimicrob. Chemother. 28: 499-504.
9. Clinical and Laboratory Standards Institute. 2006. Performance Standards for Antimicrobial Susceptibility Testing: Approved Standard M100-S16, 16th Informational Supplement, Vol. 26. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Conejo, M.C., J.R. Hernandez, and A. Pascual. 2008. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum b-lactamases or plasmid-mediated AmpC-type b-lactamases. Diagn. Microbiol. Infect. Dis. 61:343-345.
11. Doumith, M., M.J. Ellington, D.M. Livermore, and N. Woodford. 2009. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J. Antimicrob. Chemother. 63:659-667.
12. Elliott, E., A.J. Brink, J. van Greune, Z. Els, N. Woodford, J. Turton, M. Warner, and D.M. Livermore. 2006. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extendedspectrum b-lactamase. Clin. Infect. Dis. 42:e95-e98.
13. Gould, C.V., R. Rothenberg, and J.P. Steinberg. 2006. Antibiotic resistance in long-term acute care hospitals: the perfect storm. Infect. Control Hosp. Epidemiol. 27:920-925.
14. Hernandez-Alles, S., S. Alberti, D. Alvarez, A. Domenech- Sanchez, L. Martinez-Martinez, J. Gil, J.M. Tomas, and V.J. Benedi. 1999. Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 145:673-679.
15. Hernandez-Alles, S., V.J. Benedi, L. Martinez-Martinez, A. Pascual, A. Aguilar, J.M. Tomas, and S. Alberti. 1999. Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrob. Agents Chemother. 43:937-939.
16. Kaczmarek, F.M., F. Dib-Hajj, W. Shang, and T.D. Gootz. 2006. High-level carbapenem resistance in a Klebsiella pneumonia clinical isolate is due to the combination of bla ACT-1 -lactamase production, porin OmpK35=36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob. Agents Chemother. 50:3396-3406.
17. Lauderdale, T.L., L. Clifford McDonald, Y.R. Shiau, P.C. Chen, H.Y. Wang, J.F. Lai, and M. Ho. 2004. The status of antimicrobial resistance in Taiwan among gram-negative pathogens: the Taiwan surveillance of antimicrobial resistance (TSAR) program, 2000. Diagn. Microbiol. Infect. Dis. 48:211-219. (Pubitemid 38340523)
18. Lee, C.H., C. Chu, J.W. Liu, Y.S. Chen, C.J. Chiu, and L.H. Su. 2007. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 blactamases. J. Antimicrob. Chemother. 60:410-413.
19. Liu, Y.F., J.J. Yan, W.C. Ko, S.H. Tsai, and J.J. Wu. 2008. Characterization of carbapenem-non-susceptible Escherichia coli isolates from a university hospital in Taiwan. J. Antimicrob. Chemother. 61:1020-1023.
20. Mabilat, C., and S. Goussard. 1993. PCR detection and identification of genes for extended-spectrum b-lactamases. In Persing DH, Tenover FC, et al. (eds.), Diagnostic Molecular Microbiology: Principles and Applications. American Society for Microbiology, Washington, DC, pp. 553-559.
21. Mainardi, J.L., P. Mugnier, A. Coutrot, A. Buu-Hoi, E. Collatz, and L. Gutmann. 1997. Carbapenem resistance in a clinical isolate of Citrobacter freundii. Antimicrob. Agents Chemother. 41:2352-2354.
22. Mammeri, H., P. Nordmann, A. Berkani, and F. Eb. 2008. Contribution of extended-spectrum AmpC (ESAC) blactamases to carbapenem resistance in Escherichia coli. FEMS Microbiol. Lett. 282:238-240.
23. Martinez-Martinez, L., S. Hernandez-Alles, S. Alberti, J.M. Tomas, V.J. Benedi, and G.A. Jacoby. 1996. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrumcephalosporins. Antimicrob. Agents Chemother. 40:342-348.
24. Martinez-Martinez, L., A. Pascual, S. Hernandez-Alles, D. Alvarez-Diaz, A.I. Suarez, J. Tran, V.J. Benedi, and G.A. Jacoby. 1999. Roles of b-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob. Agents Chemother. 43:1669-1673.
25. Nordmann, P., and L. Poirel. 2002. Emerging carbapenemasesin Gram-negative aerobes. Clin. Microbiol. Infect. 8:321-331.
26. Nseir, S., C. Di Pompeo, B. Cavestri, E. Jozefowicz, M. Nyunga, S. Soubrier, M. Roussel-Delvallez, F. Saulnier, D. Mathieu, and A. Durocher. 2006. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: prevalence, risk factors, and outcome. Crit. Care Med. 34:2959-2966.
27. Paterson, D.L. 2000. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum b-lactamases (ESBLs). Clin. Microbiol. Infect. 6:460-463.
28. Pérez-Pérez, F.J., and N.D. Hanson. 2002. Detection of plasmid-mediated AmpC b-lactamase genes in clinical isolates by using multiple PCR. J. Clin. Microbiol. 40:2153-2162.
29. Pitout, J.D., and K.B. Laupland. 2008. Extended-spectrum b-lactamase-producing Enterobacteriaceae: an emerging public- health concern. Lancet Infect. Dis. 8:159-166.
30. Raimondi, A., A. Traverso, and H. Nikaido. 1991. Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins. Antimicrob. Agents Chemother. 35:1174-1180.
31. Rasheed, J.K., C. Jay, B. Metchock, F. Berkowitz, L. Weigel, J. Crellin, C. Steward, B. Hill, A.A. Medeiros, and F.C. Tenover. 1997. Evolution of extended-spectrum b-lactam resistance SHV-8 in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob. Agents Chemother. 41:647-653.
32. Stapleton, P.D., K.P. Shannon, and G.L. French. 1999. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 b-lactamase production and loss of an outer membrane protein. Antimicrob. Agents Chemother. 43:1206-1210.
33. Su, L.H., H.L. Chen, J.H. Chia, S.Y. Liu, C. Chu, T.L. Wu, and C.H. Chiu. 2006. Distribution of a transposon-like element carrying blaCMY-2 among Salmonella and other Enterobacteriaceae. J. Antimicrob. Chemother. 57:424-429.
34. Su, L.H., H.S. Leu, Y.P. Chiu, J.H. Chia, A.J. Kuo, C.F. Sun, T.Y. Lin, and T.L. Wu. 2000. Molecular investigation of two clusters of hospital-acquired bacteraemia caused by multiresistant Klebsiella pneumoniae using pulsed-field gel electrophoresis and in frequent restriction site PCR. J. Hosp. Infect. 46:110-117.
35. Tenover, F.C., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
36. Walsh, T.R., M.A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-b-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
37. Woodford, N., P.M. Tierno, Jr., K. Young, L. Tysall, M.F. Palepou, E. Ward, R.E. Painter, D.F. Suber, D. Shungu, L.L. Silver, K. Inglima, J. Kornblum, and D.M. Livermore. 2004. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A b-lactamase, KPC-3, in a New York Medical Center. Antimicrob. Agents Chemother. 48:4793-4799.
38. Wu, T.L., L.K. Siu, L.H. Su, T.L. Lauderdale, F.M. Lin, H.S. Leu, T.Y. Lin, and M. Ho. 2001. Outer membrane protein change combined with co-existing TEM-1 and SHV-1 b-lactamases lead to false identification of ESBLproducing Klebsiella pneumoniae. J. Antimicrob. Chemother. 47:755-761.
39. Yan, J.J., W.C. Ko, C.L. Chuang, and J.J. Wu. 2002. Metallob- lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. J. Antimicrob. Chemother. 50:503-511.
40. Yan, J.J., W.C. Ko, S.H. Tsai, H.M. Wu, and J.J. Wu. 2001. Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying blaIMP-8 in a university medical center in Taiwan. J. Clin. Microbiol. 39:4433-4439.
41. Yan, J.J., W.C. Ko, and J.J. Wu. 2001. Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP- 2 metallo-b-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:2368-2371.